Mount Yale Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-4,325
Closed -$378K – 914
2025
Q2
$378K Sell
4,325
-3,590
-45% -$281K 0.03% 403
2025
Q1
$541K Sell
7,915
-1,257
-14% -$103K 0.05% 312
2024
Q4
$713K Buy
+9,172
New +$679K 0.06% 270

Other funds holding DXCM

Mount Yale Investment Advisors's DXCM Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,325 shares — an estimated $378K sold.

Mount Yale Investment Advisors first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $713K in Q4 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 4,325 DexCom shares in Q3 2025, an estimated $378K.
  • Mount Yale Investment Advisors first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
  • Mount Yale Investment Advisors's DexCom position peaked at $713K in Q4 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.